<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="181247">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00735124</url>
  </required_header>
  <id_info>
    <org_study_id>14002</org_study_id>
    <nct_id>NCT00735124</nct_id>
  </id_info>
  <brief_title>Post-Operative Pain Scores and Analgesic Requirements After Elective Inguinal Herniorrhaphy</brief_title>
  <official_title>An Investigation of Post-Operative Pain Scores and Analgesic Requirements After Ambulatory Inguinal Herniorrhaphy With Pre-Operative Gabapentin Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oklahoma</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Oklahoma</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will investigate the effects of single dose pre-operative oral dose of gabapentin
      (1200) on post -operative pain scores and oral analgesic requirements.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will benefit patients in reducing post-operative pain scores as well as reduction
      in oral analgesic consumption. Gabapentin has been shown to reduce post operative pain pain
      scores in breast surgery, hysterectomy , spinal surgery, orthopedic and thyroid surgery
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Changes to surgical practices led to the loss of eligible patients for this study.
  </why_stopped>
  <start_date type="Actual">November 6, 2008</start_date>
  <completion_date type="Actual">September 2009</completion_date>
  <primary_completion_date type="Actual">September 2009</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Participant, Care Provider, Investigator, Outcomes Assessor</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post operative pain is reduced when single pre-operative oral dose of Gabapentine is given to the patient before the Inguinal Herniorrhaphy</measure>
    <time_frame>1yrs</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The post operative analgesia requirement is also reduced</measure>
    <time_frame>1yrs</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">5</enrollment>
  <condition>Pain</condition>
  <condition>Analgesia</condition>
  <condition>Hernia, Inguinal</condition>
  <arm_group>
    <arm_group_label>Single pre-op dose of Gabapentine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Active treatment with the study drug</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo arm for blinding the medication</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gabapentin</intervention_name>
    <description>1200 mg single dose gabapentin</description>
    <arm_group_label>Single pre-op dose of Gabapentine</arm_group_label>
    <other_name>Neurtonin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sham or placebo</intervention_name>
    <description>Injection of placebo/sham</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects having elective surgery with open unilateral Inguinal herniorraphy

        Exclusion Criteria:

          -  Non elective surgery

          -  Patients currently on gabapentin therapy

          -  Patient hypersensitive to gabapentin surgery

          -  History of alcohol or drug abuse

          -  Patients who are pregnant or who are nursing
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Badie Mansour, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>OUHSC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>OUHSC</name>
      <address>
        <city>Oklahoma</city>
        <state>Oklahoma</state>
        <zip>73152</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 17, 2017</lastchanged_date>
  <firstreceived_date>August 13, 2008</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>analgesia requirement and post operative pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Hernia, Inguinal</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Analgesics</mesh_term>
    <mesh_term>Gabapentin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
